CMS has advised Brenntag, the global market leader in chemical distribution, on all aspects of two transactions.

In the first project, Brenntag acquired Leis Polytechnik polymere Werkstoffe GmbH. The transaction was completed after receiving merger control approval. Leis Polytechnik specialises in the development, production and distribution of high-performance polymer compounds. The company supplies around 700 products for a wide range of applications across many industries in Germany, including the automotive sector, electronics, medical technology, packaging and construction.

In the second transaction, Brenntag acquired the ACU PHARMA und CHEMIE Group. ACU specialises in the milling and micronisation of products and compound mixtures. In its state-of-the-art facility, the company produces high-quality powders for customers operating in a number of industries. In addition to this customer-specific contract manufacturing, ACU sells its own micronised products, primarily lithium carbonate.

The transactions involved the following CMS lawyers:

CMS Germany – Dr Thomas Meyding, Dr Dirk Jannott, Dr Tobias Grau, Paul Rode, Philipp Schönnenbeck, Andreas Josupeit, Peter Giese, Kai-Oliver Giesa, Andreas Grunert

CMS Switzerland – Stefan Brunnschweiler, Andrea Ferchl

Lawyer(s)
Dr. Thomas Meyding, Dr. Dirk Jannott, Andreas Josupeit, Paul Rode, Dr. Tobias Grau, Dr. Andreas Grunert, Stefan Brunnschweiler LL.M., Philipp Schönnenbeck, Andrea Ferchl, Peter Giese, Dr. Kai-Oliver Giesa